Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Stock Swap -- Ignore unavailable to you. Want to Upgrade?

To: needawin who wrote (14584)	6/26/1998 9:57:00 AM
From: Tech Master	Read Replies (1) \| Respond to of 17305

needawin- I thought that I should mention here that there still is significant risk associated with CELN. I still am following the company AND I think it will be a strong performer IF they get appropriate funding. <ggg> Tech Master

To: needawin who wrote (14584)	8/12/1998 12:14:00 PM
From: Jeffrey S. Mitchell	Read Replies (2) \| Respond to of 17305

Re: RIBI Good press release today. No question about the benefits of Melacine. It's just taking way longer than anyone expected. The latest delay is that the Canadian Health Dept required RIBI to make some changes to their building which should take several months. So, until that is done, I think everyone just sits and waits. The convertible preferred they are doing is a killer. I expect the price to come straight back down after the affects of today's press release wear off. I am also wary the price went up so high today on such low volume. If it were me, I'd sell immediately and buy back much later. - Jeff